Medicines with stricter reporting requirements Individual reimbursement Danish drug interaction databases Compassionate use permits Healthcare professionals having a relationship with a company Report a side effect from medicines Reporting of incidents and accidents with medical devices Medicinal cannabis Veterinary medicines
Theme

Vaccines against COVID-19

Medicines agencies around the world are collaborating to approve and follow vaccines against COVID-19. Once the vaccines are approved, medicines authorities around the world follow up with monitoring of adverse drug reactions. Read about results, processes and new vaccines against COVID-19 in our three themes or in the question-and-answer below.

Go to theme

News and notifications

Suspicion of rare eye condition from Ozempic use to be investigated further

16 December 2024

The Danish Medicines Agency will request the European Pharmacovigilance Risk Assessment Commit-tee, PRAC, to assess two new Danish register-based studies from the University of Southern Denmark. The studies point to a potential increased risk of a rare eye condition, NAION, in patients receiving the diabetes medicine Ozempic.

EU one step closer to electronic product information

16 January 2025

2024 deadline for submitting applications concerning marketing authorisations and clinical trials

05 November 2024

Nyt lægemiddel tilføjet listen over kritiske lægemidler med forsyningsproblemer

09 December 2024